Fusion to market Unisys cloud-based software solutions
The agreement has been made keeping in view the healthcare providers, according to Fusion. Through the agreement, Fusion will offer Unisys solutions, such as Stealth Solution Suite of
The European Commission (EC) has granted orphan designation to Lundbeck’s investigational monoclonal antibody asedebart (Lu AG13909) for the treatment of Cushing’s syndrome of endogenous origin.